- Home
- DERM vs PRME Comparison
DERM vs PRME Comparison
Compare DERM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- PRME
- Stock Information
- Founded
- DERM 2014
- PRME 2019
- Country
- DERM United States
- PRME United States
- Employees
- DERM N/A
- PRME N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- PRME Medicinal Chemicals and Botanical Products
- Sector
- DERM Health Care
- PRME Health Care
- Exchange
- DERM Nasdaq
- PRME Nasdaq
- Market Cap
- DERM 181.0M
- PRME 191.7M
- IPO Year
- DERM 2021
- PRME 2022
- Fundamental
- Price
- DERM $6.28
- PRME $2.07
- Analyst Decision
- DERM Strong Buy
- PRME Buy
- Analyst Count
- DERM 2
- PRME 6
- Target Price
- DERM $10.00
- PRME $9.38
- AVG Volume (30 Days)
- DERM 104.8K
- PRME 2.4M
- Earning Date
- DERM 08-11-2025
- PRME 08-04-2025
- Dividend Yield
- DERM N/A
- PRME N/A
- EPS Growth
- DERM N/A
- PRME N/A
- EPS
- DERM N/A
- PRME N/A
- Revenue
- DERM $56,243,000.00
- PRME $3,846,000.00
- Revenue This Year
- DERM $28.99
- PRME $104.12
- Revenue Next Year
- DERM $52.61
- PRME $196.78
- P/E Ratio
- DERM N/A
- PRME N/A
- Revenue Growth
- DERM N/A
- PRME 550.76
- 52 Week Low
- DERM $3.54
- PRME $1.11
- 52 Week High
- DERM $8.25
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- DERM 38.72
- PRME 71.75
- Support Level
- DERM $6.29
- PRME $1.56
- Resistance Level
- DERM $7.13
- PRME $1.85
- Average True Range (ATR)
- DERM 0.41
- PRME 0.19
- MACD
- DERM -0.15
- PRME 0.07
- Stochastic Oscillator
- DERM 3.31
- PRME 96.74
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.